If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Michele Cilli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Neuroblastoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Growth Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Heterografts Medicine & Life Sciences
Apoptosis Medicine & Life Sciences
Therapeutic Uses Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2019

  • 3714 Citations
  • 34 h-Index
  • 118 Article

Fibrin Gels Entrapment of a Poly-Cyclodextrin Nanocarrier as a Doxorubicin Delivery System in an Orthotopic Model of Neuroblastoma: Evaluation of In Vitro Activity and In Vivo Toxicity

Viale, M., Vecchio, G., Monticone, M., Bertone, V., Giglio, V., Maric, I., Cilli, M., Bocchini, V., Profumo, A., Ponzoni, M., Emionite, L. & Rocco, M., Aug 1 2019, In : Pharmaceutical Research. 36, 8, 115.

Research output: Contribution to journalArticle

Cyclodextrins
Fibrin
Neuroblastoma
Doxorubicin
Toxicity
1 Citation (Scopus)

LncRNA EPR controls epithelial proliferation by coordinating Cdkn1a transcription and mRNA decay response to TGF-β

Rossi, M., Bucci, G., Rizzotto, D., Bordo, D., Marzi, M. J., Puppo, M., Flinois, A., Spadaro, D., Citi, S., Emionite, L., Cilli, M., Nicassio, F., Inga, A., Briata, P. & Gherzi, R., Dec 1 2019, In : Nature Communications. 10, 1, 1969.

Research output: Contribution to journalArticle

Open Access
regulators
RNA Stability
Transcription
Epithelial Cells
Messenger RNA
4 Citations (Scopus)

A high-content screening of anticancer compounds suggests the multiple tyrosine kinase inhibitor ponatinib for repurposing in neuroblastoma therapy

Sidarovich, V., De Mariano, M., Aveic, S., Pancher, M., Adami, V., Gatto, P., Pizzini, S., Pasini, L., Croce, M., Parodi, F., Cimmino, F., Avitabile, M., Emionite, L., Cilli, M., Ferrini, S., Pagano, A., Capasso, M., Quattrone, A., Tonini, G. P. & Longo, L., Jul 1 2018, In : Molecular Cancer Therapeutics. 17, 7, p. 1405-1415 11 p.

Research output: Contribution to journalArticle

Neuroblastoma
Protein-Tyrosine Kinases
Therapeutics
Pharmaceutical Preparations
Libraries
3 Citations (Scopus)

Characterization of drug release from fibrin gels loaded with different pharmaceutical and experimental doxorubicin formulations

Viale, M., Monticone, M., Maric, I., Giglio, V., Profumo, A., Aprile, A., Cilli, M., Abelmoschi, M. L. & Rocco, M., Aug 1 2018, In : Pharmacological Reports. 70, 4, p. 760-765 6 p.

Research output: Contribution to journalArticle

Fibrin
Doxorubicin
Gels
Pharmaceutical Preparations
Thrombin
3 Citations (Scopus)

CHL1 gene acts as a tumor suppressor in human neuroblastoma

Ognibene, M., Pagnan, G., Marimpietri, D., Cangelosi, D., Cilli, M., Benedetti, M. C., Boldrini, R., Garaventa, A., Frassoni, F., Eva, A., Varesio, L., Pistoia, V. & Pezzolo, A., Jan 1 2018, In : Oncotarget. 9, 40, p. 25903-25921 19 p.

Research output: Contribution to journalArticle

Neuroblastoma
Genes
Neoplasms
Heterografts
Neuronal Cell Adhesion Molecules